| 1 | Cancer | 4.44% | |
| 2 | Patients | 4.44% | |
| 3 | STAMPEDE | 2.22% | |
| 4 | Its | 2.22% | |
| 5 | Strategies | 2.22% | |
| 6 | Study | 2.22% | |
| 7 | (MMAI) | 2.22% | |
| 8 | New | 2.22% | |
| 9 | Non-Metastatic | 2.22% | |
| 10 | Multimodal | 2.22% | |
| 11 | (ARPI) | 2.22% | |
| 12 | AMR | 2.22% | |
| 13 | Improvement | 2.22% | |
| 14 | 2nd-Generation | 2.22% | |
| 15 | Identify | 2.22% | |
| 16 | Receptor | 2.22% | |
| 17 | QOL | 2.22% | |
| 18 | Colon | 2.22% | |
| 19 | Androgen | 2.22% | |
| 20 | Intelligence | 2.22% | |
| 21 | Death | 2.22% | |
| 22 | May | 2.22% | |
| 23 | Pathway | 2.22% | |
| 24 | Anemia | 2.22% | |
| 25 | Model | 2.22% | |
| 26 | Show | 2.22% | |
| 27 | U.S. | 2.22% | |
| 28 | Preclinical | 2.22% | |
| 29 | Exercise | 2.22% | |
| 30 | Benefit | 2.22% | |
| 31 | Shows | 2.22% | |
| 32 | Prostate | 2.22% | |
| 33 | Match | 2.22% | |
| 34 | Transfusion | 2.22% | |
| 35 | Meet | 2.22% | |
| 36 | Compound | 2.22% | |
| 37 | Inhibitors | 2.22% | |
| 38 | No | 2.22% | |
| 39 | ASCO | 2.22% | |
| 40 | Promise | 2.22% | |
| 41 | High-Risk | 2.22% | |
| 42 | Reduces | 2.22% | |
| 43 | Artificial | 2.22% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||